(BBWI) Bath Body Works - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0708301041

BBWI: Soaps, Candles, Lotions, Fragrances, Sanitizers

Bath & Body Works Inc. (NYSE:BBWI) is a leading specialty retailer primarily focused on home fragrance, body care, and personal hygiene products. The company operates under well-known brands such as Bath & Body Works and White Barn, leveraging a diverse distribution network that includes retail stores across the U.S. and Canada, as well as international partnerships through franchise, license, and wholesale arrangements. This strategic approach allows BBWI to maintain a strong market presence while exploring global growth opportunities.

BBWIs product portfolio encompasses a wide range of items, including candles, soaps, sanitizers, and body care products. The company has successfully expanded its reach through e-commerce, which has been a key driver of recent growth. With a significant number of stores and a robust online platform, BBWI continues to adapt to evolving consumer preferences, ensuring relevance in a competitive retail landscape.

From a financial standpoint, BBWI boasts a market capitalization of approximately $7.68 billion, with a trailing P/E ratio of 8.80 and a forward P/E of 9.58, indicating moderate valuation levels. The price-to-sales ratio of 1.04 reflects a reasonable valuation relative to its revenue. However, the absence of a P/B ratio may signal potential concerns regarding the companys book value, which could be a point of scrutiny for investors.

Investors should consider the risks associated with BBWI, including intense competition in the retail sector, potential disruptions in global supply chains, and the challenges of maintaining growth in a saturated market. Despite these risks, BBWIs strong brand recognition and strategic initiatives position it as a contender in the specialty retail industry, warranting careful consideration for those assessing investment opportunities in this space.

Additional Sources for BBWI Stock

BBWI Stock Overview

Market Cap in USD 6,597m
Sector Consumer Cyclical
Industry Specialty Retail
GiC Sub-Industry Other Specialty Retail
IPO / Inception 1985-07-01

BBWI Stock Ratings

Growth 5y 27.0%
Fundamental -37.6%
Dividend 64.1%
Rel. Strength Industry -39
Analysts 3.85/5
Fair Price Momentum 27.39 USD
Fair Price DCF 68.60 USD

BBWI Dividends

Dividend Yield 12m 2.40%
Yield on Cost 5y 6.62%
Annual Growth 5y 26.91%
Payout Consistency 86.0%

BBWI Growth Ratios

Growth Correlation 3m -37.9%
Growth Correlation 12m -51.3%
Growth Correlation 5y 12.3%
CAGR 5y 19.77%
CAGR/Max DD 5y 0.30
Sharpe Ratio 12m -0.49
Alpha -42.49
Beta 0.92
Volatility 58.80%
Current Volume 6502.5k
Average Volume 20d 4826k
What is the price of BBWI stocks?
As of March 12, 2025, the stock is trading at USD 29.80 with a total of 6,502,467 shares traded.
Over the past week, the price has changed by -12.99%, over one month by -15.52%, over three months by -21.89% and over the past year by -32.85%.
Is Bath Body Works a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Bath Body Works (NYSE:BBWI) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -37.55 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BBWI as of March 2025 is 27.39. This means that BBWI is currently overvalued and has a potential downside of -8.09%.
Is BBWI a buy, sell or hold?
Bath Body Works has received a consensus analysts rating of 3.85. Therefor, it is recommend to buy BBWI.
  • Strong Buy: 7
  • Buy: 4
  • Hold: 8
  • Sell: 1
  • Strong Sell: 0
What are the forecast for BBWI stock price target?
According to ValueRays Forecast Model, BBWI Bath Body Works will be worth about 30.2 in March 2026. The stock is currently trading at 29.80. This means that the stock has a potential upside of +1.41%.
Issuer Forecast Upside
Wallstreet Target Price 46.5 56%
Analysts Target Price 45.3 52.1%
ValueRay Target Price 30.2 1.4%